Serum Amyloid A Protein as a useful biomarker to predict COVID-19 patients severity and prognosis
Sign Up to like & getrecommendations! Published in 2021 at "International Immunopharmacology"
DOI: 10.1016/j.intimp.2021.107512
Abstract: Coronavirus Disease 2019 (COVID-19) can present with different grades of severity from mild to critical. Evaluation of biomarkers predicting severity is crucial to identify patients at high risk of disease progression and poor prognosis. Serum… read more here.
Keywords: protein; prognosis serum; prognosis; survivors non ... See more keywords